ACHV: Receives FDA Response
Achieve Life Sciences Receives FDA's Complete Response Letter Regarding New Drug Application For Cytisinicline; FDA Identifies No Deficiencies Regarding Clinical Efficacy, Safety Of Cytisinicline
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.